Orris
attachment
attachment
attachment
attachment

Tell me moa clinical uses and adverse effect and contra indications

Reading File
The prescription contains 6 drugs. I'll search the medical library for all of them in parallel:
  1. FEXET 120 mg = Fexofenadine (antihistamine)
  2. HY-CORTISONE 100 mg = Hydrocortisone (corticosteroid)
  3. OXIDIL 2 GM IV = likely Oxacillin or Amoxicillin-Clavulanate (antibiotic)
  4. SCIMONT 10 mg = Montelukast (leukotriene antagonist)
  5. AVELON 400 mg = Moxifloxacin (fluoroquinolone antibiotic)
  6. COMBIHALE NEBULES = Budesonide + Formoterol (inhaled corticosteroid + LABA)
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I found good leads. Let me read the key sections for the most relevant content:
Reading File
Reading File
Reading File
I have enough foundational information. Now I'll compile a comprehensive answer for all 6 drugs from the prescription.

Prescription Drug Review

The prescription contains 6 drugs. Here is the MOA, clinical uses, adverse effects, and contraindications for each:

1. 🟦 FEXET 120 mg (Fexofenadine) β€” PO OD

Mechanism of Action

Selective, peripheral H1-receptor antagonist (second-generation antihistamine). It does NOT cross the blood-brain barrier significantly, hence minimal sedation. It is a metabolite of terfenadine.

Clinical Uses

  • Seasonal allergic rhinitis (hay fever)
  • Chronic idiopathic urticaria (hives)
  • Allergic conjunctivitis
  • Pruritus (itching) β€” in combination with montelukast

Adverse Effects

  • Headache, dizziness (mild)
  • Nausea, dyspepsia
  • Fatigue (less than older antihistamines)
  • No significant CNS sedation (major advantage)

Contraindications

  • Hypersensitivity to fexofenadine
  • Drug interaction: Avoid with grapefruit juice (inhibits OATP transporters β†’ reduced drug absorption)
  • Use with caution in renal impairment (dose reduction needed)

2. 🟧 HY-CORTISONE 100 mg IV TDS (Hydrocortisone / Cortisol)

Mechanism of Action

Glucocorticoid (and mild mineralocorticoid). Binds intracellular glucocorticoid receptors β†’ alters gene transcription β†’ suppresses inflammatory cytokines (IL-1, IL-6, TNF-Ξ±), stabilizes mast cells, inhibits phospholipase A2 (reducing prostaglandin/leukotriene synthesis).

Clinical Uses

  • Acute allergic reactions and anaphylaxis (IV)
  • Acute severe asthma / status asthmaticus
  • Adrenal insufficiency / Addisonian crisis
  • Inflammatory conditions (IBD, autoimmune disease)
  • Shock (septic, anaphylactic)
  • Congenital adrenal hyperplasia (replacement)

Adverse Effects

With short-term IV use (as prescribed here, TDS): generally well tolerated. With prolonged use:
  • Hyperglycemia, HPA axis suppression
  • Hypertension, fluid/sodium retention (mineralocorticoid effect)
  • Immunosuppression (opportunistic infections)
  • Osteoporosis, peptic ulcer
  • Cushing's syndrome (cushingoid features)
  • Psychiatric effects (mood changes, insomnia)

Contraindications

  • Active untreated infections (relative CI)
  • Live vaccines during therapy
  • Systemic fungal infections (absolute)
  • Peptic ulcer disease (relative)

3. 🟩 EUROCAP NS 100 mL (Normal Saline β€” IV Fluid)

This is simply 0.9% Sodium Chloride β€” used as a IV vehicle/diluent for hydrocortisone and as maintenance fluid. No pharmacological MOA. CI: hypernatremia, fluid overload states.

4. πŸŸ₯ OXIDIL 2 GM IV OD (Oxacillin β€” Beta-lactam Antibiotic)

(OXIDIL is a brand name for Oxacillin in several countries)

Mechanism of Action

Beta-lactam antibiotic (penicillinase-resistant penicillin). Inhibits bacterial cell wall synthesis by binding to Penicillin Binding Proteins (PBPs), preventing peptidoglycan cross-linking β†’ cell lysis. Resistant to staphylococcal beta-lactamase.

Clinical Uses

  • Staphylococcal infections (MSSA β€” methicillin-sensitive S. aureus)
  • Cellulitis, skin and soft tissue infections
  • Septicemia, osteomyelitis, endocarditis due to MSSA
  • Post-operative wound infections

Adverse Effects

  • Hypersensitivity reactions (urticaria, rash, anaphylaxis)
  • GI: nausea, diarrhea
  • Hepatotoxicity (elevated liver enzymes β€” monitor LFTs)
  • Neutropenia, thrombocytopenia (with prolonged use)
  • Interstitial nephritis (rare)

Contraindications

  • Penicillin allergy / hypersensitivity
  • MRSA infections (oxacillin is ineffective against MRSA)

5. πŸŸͺ SCIMONT 10 mg (Montelukast β€” Leukotriene Receptor Antagonist)

Mechanism of Action

Selectively blocks cysteinyl leukotriene type 1 (CysLT1) receptors β€” blocks the action of leukotrienes (LTD4, LTC4, LTE4), which are potent bronchoconstrictors and pro-inflammatory mediators released by mast cells and eosinophils.

Clinical Uses

  • Bronchial asthma β€” prophylaxis and maintenance (especially in children)
  • Allergic rhinitis (seasonal and perennial)
  • Exercise-induced bronchoconstriction prophylaxis
  • Aspirin-induced asthma (particularly effective)
  • Chronic urticaria (in combination with antihistamines)

Adverse Effects

  • Headache
  • GI disturbances (abdominal pain, nausea)
  • Neuropsychiatric effects (FDA black box warning): mood changes, depression, suicidal ideation, nightmares β€” especially in pediatric patients
  • Elevated liver enzymes (rare)
  • Churg-Strauss syndrome (rare, with steroid tapering)

Contraindications

  • Hypersensitivity to montelukast
  • Not for acute bronchospasm (not a bronchodilator)
  • History of neuropsychiatric illness (relative CI)
  • Phenylketonuria (if chewable tablets containing phenylalanine)

6. πŸ”΅ AVELON 400 mg PO OD (Moxifloxacin β€” Fluoroquinolone)

Mechanism of Action

4th-generation fluoroquinolone. Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV β†’ prevents DNA replication, transcription, and repair β†’ bactericidal. Excellent coverage: Gram-positive (including S. pneumoniae), Gram-negative, atypicals (Mycoplasma, Chlamydia, Legionella), and anaerobes.

Clinical Uses

  • Community-acquired pneumonia (CAP) β€” first-line
  • Acute bacterial exacerbation of chronic bronchitis (ABECB)
  • Sinusitis, skin and soft tissue infections
  • Intra-abdominal infections (due to anaerobic coverage)
  • Tuberculosis (second-line)
  • NOT for UTIs (does not achieve adequate urinary concentrations)

Adverse Effects

  • QTc prolongation (risk of torsades de pointes β€” serious)
  • GI: nausea, diarrhea, abdominal pain
  • CNS: dizziness, headache, insomnia
  • Tendinopathy / tendon rupture (especially Achilles β€” increased risk in elderly and steroid users)
  • Peripheral neuropathy
  • Photosensitivity
  • Hepatotoxicity

Contraindications

  • QT prolongation or concurrent use of QT-prolonging drugs
  • Patients on Class IA or III antiarrhythmics
  • Myasthenia gravis (may worsen neuromuscular blockade)
  • Hypersensitivity to fluoroquinolones
  • Pregnancy and children (cartilage damage risk)
  • Avoid in patients already on corticosteroids (↑ tendon rupture risk β€” note: this patient IS on hydrocortisone; monitor)

7. πŸ”΄ COMBIHALE NEBULES QID (Budesonide + Formoterol)

Mechanism of Action

Combination of:
  • Budesonide (inhaled corticosteroid/ICS): binds glucocorticoid receptors β†’ reduces airway inflammation, mucus production, bronchial hyperreactivity
  • Formoterol (long-acting beta-2 agonist/LABA): stimulates Ξ²2-adrenoceptors on bronchial smooth muscle β†’ activates adenylyl cyclase β†’ ↑ cAMP β†’ bronchodilation (onset within 1–3 min, duration 12 h)

Clinical Uses

  • Moderate-to-severe asthma maintenance therapy
  • COPD β€” maintenance and exacerbation prevention
  • Acute asthma exacerbation (via nebulization, as prescribed QID)
  • Prevents exercise-induced bronchospasm

Adverse Effects

Budesonide (inhaled):
  • Oral candidiasis (thrush) β€” rinse mouth after use
  • Dysphonia (hoarse voice)
  • Mild HPA axis suppression at high doses
Formoterol (LABA):
  • Tachycardia, palpitations, tremor
  • Hypokalemia (especially with IV hydrocortisone β€” monitor K⁺ in this patient)
  • Hyperglycemia
Combined:
  • Paradoxical bronchospasm (rare)

Contraindications

  • Monotherapy with LABA (without ICS) in asthma (↑ asthma-related death risk)
  • Hypersensitivity to budesonide or formoterol
  • Acute severe bronchospasm requiring only short-acting bronchodilator (SABA is preferred for rescue)

⚠️ Important Clinical Notes for This Prescription

InteractionConcern
Hydrocortisone IV + FormoterolBoth cause hypokalemia β€” monitor serum K⁺
Hydrocortisone + MoxifloxacinBoth may prolong QTc and corticosteroids increase tendon rupture risk with fluoroquinolones
MoxifloxacinAvoid concurrent antacids/dairy within 4 hours (chelation reduces absorption)
This is a classic prescription for a patient with acute severe asthma or allergic bronchospasm with superimposed respiratory infection β€” combining anti-inflammatory, bronchodilator, antihistamine, leukotriene blocker, and antibiotic therapy.
This is a shared conversation. Sign in to Orris to start your own chat.